Senior Biopharma Executive Joins MMS Holdings as Principal Medical Director
CANTON, Mich.--(BUSINESS WIRE)-- #biotech--MMS Holdings, a data-focused contract research organization (CRO), announced the addition of Robert Allen, MD, to its team as Principal Medical Director of Global Drug Safety and Pharmacovigilance. Bringing more than 20 years of pharmaceutical industry experience, Dr. Allen has worked at Parke Davis, Pfizer, Adolor, AstraZeneca,...
